| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Mitchell Stephen Ray is a Director at Vanda Pharmaceuticals Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $563K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | VNDA Vanda Pharmaceuticals Inc. | Director | Sell | 7,000 | $4.59 | $32,130.00 | -6.7% | +2.0% | +30.2% | |
| Nov 14, 2024 | VNDA Vanda Pharmaceuticals Inc. | Director | Sell | 5,000 | $5.17 | $25,863.00 | -10.0% | -6.9% | -14.7% | |
| Aug 10, 2023 | VNDA Vanda Pharmaceuticals Inc. | Director | Sell | 6,500 | $6.05 | $39,349.05 | -18.1% | -28.1% | -13.8% | |
| Jun 13, 2022 | VNDA Vanda Pharmaceuticals Inc. | Director | Sell | 2,700 | $9.48 | $25,593.03 | -29.3% | +10.6% | -29.8% | |
| Sep 9, 2021 | VNDA Vanda Pharmaceuticals Inc. | Director | Sale+OE | 19,109 | $16.74 | $319,976.38 | -67.5% | -1.6% | -37.8% | |
| Jun 15, 2021 | VNDA Vanda Pharmaceuticals Inc. | Director | Sale+OE | 5,000 | $19.42 | $97,122.00 | -35.2% | -14.0% | -50.3% |